MedTrace Logo

Mechanistic Basis of Ablative Carbon Dioxide Laser in Treating Hypertrophic Scars

NCT04736251 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-11-08

No results posted yet for this study

Summary

This is an observational cohort study which will look at the biomarkers from blood and tissue sample for adult patients with hypertrophic scarring due to burns/trauma incident over 12 months from date of recruitment. The study will assess the kinetics of the response to fractionated carbon dioxide laser therapy in hypertrophic scars.

Conditions

  • Burn Scar
  • Scar

Sponsors & Collaborators

  • The Scar Free Foundation Centre for Conflict Wound Research

    collaborator UNKNOWN

  • University of Birmingham

    collaborator OTHER

  • Welsh Centre for Burns and Plastic Surgery, Morriston Hospital

    collaborator UNKNOWN

  • Naiem Moiemen

    lead OTHER

Principal Investigators

  • Naiem Moiemen, GMC · University Hospital Birmingham NHS Foundation Trust

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-09
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04736251 on ClinicalTrials.gov